Fertirelin vs Gonadorelin (GnRH) — Peptide Comparison

Fertirelin vs Gonadorelin (GnRH) — Peptide Comparison Fertirelin vs Gonadorelin (GnRH) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Fertirelin 25 micrograms–100 micrograms mg Gonadorelin (GnRH) 0.1-1.5–3-10 mg Frequency Once daily Administration Intramuscular injection Subcutaneous injection Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy Reproductive Synchronization Hormone Support Veterinary Breeding Enhancement Reproductive Health Hormone Balance Ovulation Support Technical Data Molecular Formula C55H76N16O12 Molecular Weight 1153.3 g/mol Half-Life Variable depending on formulation; sustained-release formulations extend duration Bioavailability High when administered via injection CAS Number 66002-66-2 C55H75N17O13 1182.3 2-4 minutes Varies by route: ~5-20% (intranasal), 100% (IV/IM injections) 34973-08-5 Protocols standard 50-100 mcg per animal Single injection at the defined point in the synchronization protocol Single dose (repeated per breeding cycle as needed) Fertirelin is a veterinary GnRH agonist. In dairy cattle, 50 mcg and 100 mcg intramuscular both triggered an LH surge and comparable conception rates for ovulation synchronization and fixed-time insemination [4]. Used to induce ovulation and improve conception in cattle [1]. 100 mcg Single dose One-time diagnostic test FDA-labeled gonadotropin (LH/FSH) stimulation test for pituitary reserve; 100 mcg given once subcutaneously (or IV), with LH measured at 0, 15, 30, 45, 60 and 120 minutes (Factrel) [4]. 5 mcg per pulse (range 1-20 mcg) Every 90 minutes via pulsatile pump One or more ovulatory cycles; reassessed at 21-day intervals FDA-labeled pulsatile regimen for ovulation induction in hypothalamic amenorrhea (Lutrepulse); intravenous pulsatile delivery gave better results than subcutaneous [5]. The 2-4 minute half-life makes pulsatile delivery essential. Applications Livestock breeding programs Fertirelin is particularly well-suited for individuals focused on livestock breeding programs. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Reproductive synchronization in cattle Fertirelin is particularly well-suited for individuals focused on reproductive synchronization in cattle. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Fertility enhancement in veterinary settings Fertirelin is particularly well-suited for individuals focused on fertility enhancement in veterinary settings. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Research on reproductive hormone mechanisms Fertirelin is particularly well-suited for individuals focused on research on reproductive hormone mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Improving fertility and conception chances Gonadorelin (GnRH) is particularly well-suited for individuals focused on improving fertility and conception chances. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Regulating irregular menstrual cycles Gonadorelin (GnRH) is particularly well-suited for individuals focused on regulating irregular menstrual cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Enhancing reproductive hormone levels Gonadorelin (GnRH) is particularly well-suited for individuals focused on enhancing reproductive hormone levels. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Supporting natural pregnancy attempts Gonadorelin (GnRH) is particularly well-suited for individuals focused on supporting natural pregnancy attempts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Safety Profile Common Mild discomfort at treatment site Transient hormone fluctuations Temporary behavioral changes in animals Mild injection site reactions Short-term changes in appetite Temporary mood variations Minimal systemic effects at therapeutic doses Uncommon Occasional swelling at injection site Serious Severe allergic reaction Mild headache Local injection site reactions (redness, swelling) Temporary hot flashes Mood changes or emotional sensitivity Nausea or mild stomach upset Allergic skin reactions Dizziness or lightheadedness Temporary changes in vision Joint or muscle aches Insomnia or sleep disturbances Severe allergic reactions (difficulty breathing, swelling) Severe hormonal imbalance symptoms Ovarian hyperstimulation syndrome (OHSS) Signs of blood clots (chest pain, leg swelling) Severe mood changes or depression Research Status FDA Status Research compound Safety Overview Fertirelin is a GnRH agonist developed specifically for veterinary use in livestock, particularly cattle breeding and fertility management. The peptide has been safely used in veterinary medicine for over 40 years with a well-documented safety profile in animals. Important limitation: Fertirelin is NOT approved for human use. All safety and efficacy data comes from veterinary applications in cattle and limited laboratory research. Human safety data is minimal and extrapolation from veterinary use is problematic. The biphasic response (initial hormone surge followed by suppression) must be carefully managed in any application. Individual responses can vary significantly based on age, hormonal status, and concurrent medications. Contraindications xPregnancy (may disrupt existing pregnancy) xHypersensitivity to GnRH analogs xActive reproductive infections xConcurrent use with certain medications xUndiagnosed reproductive disorders FDA approved for this use Gonadorelin is native GnRH and carries the safety profile established over 40+ years of clinical use in reproductive endocrinology. As the body's natural hormone, it produces minimal local side effects when dosed appropriately. The critical safety concern with gonadorelin is the initial flare effect within 24-48 hours of first dose—temporary elevation in FSH and LH—which can paradoxically suppress sex hormones before the desired stimulation occurs. This flare makes gonadorelin unsuitable for some conditions and explains why synthetic analogs (agonists, antagonists) are preferred in many modern fertility protocols. xPregnancy or breastfeeding xHormone-sensitive cancers (breast, prostate, ovarian) xSevere pituitary or hypothalamic disease xUndiagnosed abnormal vaginal bleeding xKnown hypersensitivity to GnRH Decision Guide Choose Fertirelin if... Livestock breeding programs Reproductive synchronization in cattle Fertility enhancement in veterinary settings Research on reproductive hormone mechanisms Choose Gonadorelin (GnRH) if... Improving fertility and conception chances Regulating irregular menstrual cycles Enhancing reproductive hormone levels Supporting natural pregnancy attempts